CompoAtlas

Chlorophylle magnésienne

Food supplement declared in France, declaration No 2023-6-504, decision dated 8 June 2023

Chlorophylle magnésienne (Biophenix) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 rules of use apply to its ingredients (limits and warnings).

Brand
Biophenix
Food business operator placing the product on the market
GREEN TIME SA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules par jour
Not recommended for (according to the manufacturer)
Antécédent de cancer du sein

Declaration 195851, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Medicago sativa L.FeuilleExtrait sec alcoolique400 mg
Urtica dioica L.FeuillePoudre (de plantes séchées ou broyées)400 mg

Additives

Hydroxypropyl Méthyl Cellulose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Biophenix

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line